Aluzaite Kristina, Soares Marta O, Hewitt Catherine, Hope William, Robotham Julie, Woods Beth
Centre for Health Economics, University of York, York, UK.
York Trials Unit, Department of Health Sciences, University of York, York, UK.
Appl Health Econ Health Policy. 2025 May 9. doi: 10.1007/s40258-025-00969-6.
Antimicrobial resistance (AMR) is a complex, inter-sectoral and international problem. Economic evaluation (EE) methods offer systematic, evidence-driven approaches to inform policy decisions about which AMR interventions to fund. EE of AMR interventions is complicated owing to diffuse effects, complex mechanics of the problem and high levels of uncertainty. Current AMR EE literature restricts the analytical scope, potentially resulting in omissions of effects that may limit the utility of EE to inform policy decisions. We aimed to systemise the key evolutionary and ecological processes of AMR to elucidate the paths through which AMR interventions impact population health and healthcare costs to support EE design and to support decision makers in understanding the limitations of EE evidence for decision-making.
A conceptual map and a corresponding tool were developed on the basis of a literature review in consultation with experts across the relevant disciplines of molecular biology, infectious disease modelling, health economics and ecology.
The AMR development map: (1) distils the key AMR processes and process drivers behind AMR development and maps the available types of AMR interventions to AMR process drivers; (2) proposes a way to conceptualise the spatial scope of analysis through considering the connectivity of the wider ecosystem and (3) outlines the key dimensions that AMR burden and intervention effects could be measured across. An AMR development map tool was developed to support conceptual modelling, with the focus on the choice of scope in the EE of AMR interventions, and an illustrative case study was provided.
This work summarises the key underlying biological principles of AMR development to provide mechanistical grounding for considering the scope of effects of AMR interventions and the appropriate system of analysis to support conceptual modelling in EE of AMR interventions. In addition, this map can facilitate the identification of effects that cannot be considered or quantified, thus enabling transparency about these omissions within decision-making.
抗菌药物耐药性(AMR)是一个复杂的、跨部门的国际性问题。经济评估(EE)方法提供了系统的、基于证据的方法,为关于资助哪些AMR干预措施的政策决策提供信息。由于AMR干预措施的广泛影响、问题的复杂机制和高度的不确定性,AMR干预措施的经济评估很复杂。当前的AMR经济评估文献限制了分析范围,可能导致遗漏一些影响,这可能会限制经济评估为政策决策提供信息的效用。我们旨在将AMR的关键进化和生态过程系统化,以阐明AMR干预措施影响人群健康和医疗成本的途径,以支持经济评估设计,并帮助决策者理解经济评估证据在决策中的局限性。
在与分子生物学、传染病建模、卫生经济学和生态学等相关学科的专家协商进行文献综述的基础上,绘制了一个概念图并开发了一个相应的工具。
AMR发展图:(1)提炼出AMR发展背后的关键AMR过程和过程驱动因素,并将可用的AMR干预措施类型映射到AMR过程驱动因素;(2)通过考虑更广泛生态系统的连通性,提出了一种概念化分析空间范围的方法;(3)概述了可以衡量AMR负担和干预效果的关键维度。开发了一个AMR发展图工具来支持概念建模,重点是AMR干预措施经济评估中的范围选择,并提供了一个说明性案例研究。
这项工作总结了AMR发展的关键潜在生物学原理,为考虑AMR干预措施的影响范围和支持AMR干预措施经济评估概念建模的适当分析系统提供了机制基础。此外,这张图可以促进识别那些无法考虑或量化的影响,从而在决策过程中使这些遗漏透明化。